Pesquisar este blog


sexta-feira, 14 de dezembro de 2012

Comparisons Show Why America’s Nano Labs Could Bring Returns of 500% to 1,000% in the Mid Term

The fancy term these days for learning from the past is "pattern recognition." It’s uttered frequently by investors, business professionals, politicians and military strategists. They observe patterns of behavior in the world around them, and they remember that in the past similar patterns had certain consequences.

Most detailed view of matter ever photographed (single molecule)

So it is that observers of nanotechnology are seeing signs now of patterns that happen to be extremely positive, particularly in relation to Nano Labs Corp. (OTCQB: CTLE). But before getting to that, let’s explore the bigger picture.
History tells us that government funding for science and technology contributes to patterns wherein new ventures materialize and some of them prosper. It so happens that in recent years public funds have been generously earmarked and increased for science and technology, particularly emerging technologies.
Looking back to the year 2,000, we see that the funding pump was primed and private enterprise rushed in, with the result that biotech boomed. For instance, investors pumped billions into genomics-related companies such as Celera Genomics (nyse: CRA), Incyte Genomics (nasdaq: INCY), Human Genome Sciences (nasdaq: HGSI), Affymetrix (nasdaq: AFFX) and CuraGen (nasdaq: CRGN). Stocks soon zoomed upwards, creating tens of billions of dollars in paper wealth.
Later in the decade we saw the pattern repeat through the likes of companies such as Veeco Instruments Inc.(nasdaq: VEECO), which offered stellar expertise and a broad range of innovative products including everything from photovoltaics, semiconductors, wireless components, microelectromechanical systems, and other next-generation devices.
How can traders best grow and spread risk throughout investments in nanotechnology? The answer is found in Nano Labs Corp. (OTCQB: CTLE), whose diversified, comprehensive nanotech innovations cover energy, health & medicine, and food & agriculture.

In 2009 Veeco stock stood at just over $4.90, but by 2011 it hit a high of $55, representing a 1,000% increase in 24 months. That the stock more recently slipped back to the $30 range is not welcome news, but it is hardly disquieting news given the overall gains. Through Veeco, it’s possible to draw positive parallels with Nano Labs.
At the same time that Nano Labs has brought together stellar scientific and expertise and a large and diverse portfolio of innovative products in nanotechnology, news has come from the U.S. government that for fiscal 2013 it is increasing funding for emerging technologies to more than $13 billion for key R&D departments and initiatives, highlighting in particular emerging technologies.
Thus, we see a pattern for success once more taking shape, with parallels at work right now in relation to Nano Labs. Is it therefore possible to forecast that growth by the company could match that of Veeco Instruments’ meteoric rise? Any observant soul would have to say yes, it’s very possible.